“Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients”. Pakistan Journal of Medical & Cardiological Review, vol. 5, no. 1, Jan. 2026, pp. 163-74, https://doi.org/10.5281/zenodo.18345788.